SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-007050
Filing Date
2018-05-15
Accepted
2018-05-15 16:06:23
Documents
41
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 503741
2 ex31-1.htm EX-31.1 8959
3 ex31-2.htm EX-31.2 8805
4 ex32-1.htm EX-32.1 6668
  Complete submission text file 0001493152-18-007050.txt   1887690

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE rttr-20180331.xml EX-101.INS 196329
6 XBRL SCHEMA FILE rttr-20180331.xsd EX-101.SCH 21804
7 XBRL CALCULATION FILE rttr-20180331_cal.xml EX-101.CAL 26026
8 XBRL DEFINITION FILE rttr-20180331_def.xml EX-101.DEF 79662
9 XBRL LABEL FILE rttr-20180331_lab.xml EX-101.LAB 171591
10 XBRL PRESENTATION FILE rttr-20180331_pre.xml EX-101.PRE 134134
Mailing Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067
Business Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067 310-203-1000
RITTER PHARMACEUTICALS INC (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37428 | Film No.: 18836400
SIC: 2834 Pharmaceutical Preparations